An interventional study of Navigation Intervention and Usual Care in Breast Cancer, sponsored by Medical College of Wisconsin. Not yet recruiting at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-12.
Sponsored by Medical College of Wisconsin · Not applicable, Interventional, and Health services research
Among 23 studies in Breast Neoplasms by Medical College of Wisconsin — 7 open to participants now, 11 under way, none of them phase 3. Breast Neoplasms · Medical College of Wisconsin.
Among the 23 studies in Breast Neoplasms by Medical College of Wisconsin, this one is the 9th largest by planned enrollment of the 17 interventional ones that give a count, is the only one that started in 2027, is one of 12 with no phase, reaches primary completion later than 10 of the 10 other live ones, and was the 23rd registered.
14,825 studies on the registry are indexed under Breast Neoplasms; 3,319 are open to participants now.
Browse Breast Neoplasms studies →7 of the 23 studies in Breast Neoplasms by Medical College of Wisconsin are open now, in 1 country. Recruiting first, the newest first:
Medical College of Wisconsin · Sites in United States
Ages 65+
Medical College of Wisconsin · Sites in United States
Ages 18+ · Women only
Medical College of Wisconsin · Sites in United States
Ages 18+
Medical College of Wisconsin · Sites in United States
Ages 30–75 · Healthy volunteers
Medical College of Wisconsin · Sites in United States
Ages 18+ · Women only
By country, each count listing its studies:
Of the 2,400 Breast Neoplasms studies recruiting now, 1,572 (66%) set no upper age limit and 591 (25%) stop at 75 or younger; 103 take children under 18; 214 take healthy volunteers.
This study: 18 Years and older · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
23 studies; the count open now beside each. This study's row is marked.
First in 2011; this study’s year is marked. 1 started in 2027.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 45 is below the median of 72 across 10,896 interventional studies indexed under Breast Neoplasms.
Median enrollment 45 across the 17 interventional studies, 75 across the 6 observational. Of the 10 that completed or were terminated, 2 (20%) have results posted.
This tab as a report to print or save as PDF → With an account.
Medical College of Wisconsin is the lead sponsor of 549 studies on the registry; 123 are open to participants now.
Of its 75 completed or terminated interventional studies of FDA-regulated products, 57 (76%) have results posted.
4 of the studies in Breast Neoplasms by Medical College of Wisconsin that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05223322Medical College of WisconsinUnderstanding and Addressing Disparities in Cancer Therapy Induced Inflammation and Associated Endothelial Dysfunction | 2026-12-31 |
| NCT07227077Medical College of WisconsinDosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial | 2027-05-01 |
| NCT02783664Medical College of WisconsinEvaluating the Effects of Genetic Testing on Patients' Stress Levels | 2027-07 |
| NCT06106477Medical College of WisconsinImpact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer | 2027-07-15 |
Add all 4 to your calendar (.ics) → With an account.
Among the 23 studies in Breast Neoplasms by Medical College of Wisconsin, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This is a two-arm, open-label, randomized interventional study involving women newly diagnosed with breast cancer.
This project seeks to address inequities in participation in clinical trials, which are defined as studies that are prospectively evaluating the effects of an intervention, among women through a structured patient navigation program that focuses on provided education about clinical trials.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Only patients assigned to Arm 1 (Navigation) will be provided clinical trial education by the navigator ahead of MD consultation.
Other: Navigation Intervention
Patients will only have an MD consultation about clinical trials.
Other: Usual Care
Women assigned to Arm 1 will receive tailored navigation services, including clinical trial education starting before their first MD consult and continuing throughout their treatment, which may include recruitment to a clinical trial.
Arm 2 will receive usual care, which includes MD consultation and execution of the resultant care plan.
Feasibility of conducting a future clinical trial
This will be measured by 100% of recruitment goal within 12 months of enrollment opening date; 80% completion of A-ARTQ post clinical trial education; 70% completion of 6-month follow-up post initial MD consultation. The ARTQ is a validated questionnaire to better understand patient perceptions of participating in a randomized clinical trial. To ensure an appropriate literacy level, the survey being used for this study was adapted to improve readability, clarity and patient understanding (A-ARTQ).
Time frame: 1 Year
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Jan 2027; primary completion for Jan 2029, 24 months later.
Of 2,661 non-industry interventional studies with no phase under Breast Neoplasms, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 66. This study's planned 24 months is below that.
Counting every sponsor, half of 2,771 studies reached it within 33 months; a quarter within 15 and three quarters within 66.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Medical College of Wisconsin →